72
Participants
Start Date
September 30, 2011
Primary Completion Date
March 31, 2012
Study Completion Date
March 31, 2012
CardioGen-82
CardioGen-82 was not administered as part of this trial but the patients enrolled had to have received CardioGen-82 previously
CardioGen-82
Patients do not received CardioGen-82 as part of this study. To be in the study they would have had to receive CardioGen-82 previously.
Bracco Diagnostics, Inc., Princeton
Lead Sponsor
Bracco Diagnostics, Inc
INDUSTRY